Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Amundi

Amundi lessened its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 22.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 82,518 shares of the company’s stock after selling 23,600 shares during the period. Amundi’s holdings in Ryan Specialty were worth $5,044,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of RYAN. Assetmark Inc. acquired a new position in shares of Ryan Specialty during the third quarter valued at approximately $34,000. Principal Securities Inc. increased its position in shares of Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after purchasing an additional 415 shares during the period. Quarry LP increased its position in shares of Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after purchasing an additional 422 shares during the period. Loomis Sayles & Co. L P raised its stake in shares of Ryan Specialty by 26.3% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock worth $91,000 after buying an additional 286 shares in the last quarter. Finally, R Squared Ltd acquired a new stake in shares of Ryan Specialty in the fourth quarter valued at $92,000. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Trading Up 2.3 %

Shares of NYSE RYAN opened at $69.86 on Friday. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a one year low of $48.48 and a one year high of $75.97. The business has a 50-day moving average price of $67.11 and a two-hundred day moving average price of $67.74. The firm has a market capitalization of $18.30 billion, a PE ratio of 101.25, a PEG ratio of 1.19 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. As a group, analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be issued a dividend of $0.12 per share. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Tuesday, March 4th. Ryan Specialty’s payout ratio is currently 69.57%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on RYAN shares. Royal Bank of Canada dropped their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a research report on Friday, February 21st. UBS Group increased their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Keefe, Bruyette & Woods decreased their price target on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a research report on Friday, February 21st. Morgan Stanley initiated coverage on Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price objective for the company. Finally, Wells Fargo & Company lifted their target price on Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a report on Friday, February 21st. One analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $75.27.

Insider Transactions at Ryan Specialty

In other news, Director Nicholas Dominic Cortezi sold 31,409 shares of Ryan Specialty stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the completion of the sale, the director now directly owns 2,697 shares in the company, valued at $177,031.08. The trade was a 92.09 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last ninety days, insiders have sold 281,451 shares of company stock valued at $18,549,143. 11.10% of the stock is owned by insiders.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.